Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen

Obstetrics and Gynecology

Volumn 117, Issue 1, 2011, Pages 33-40

  Dinger, Jürgen ^a   Do Minh, Thai ^a   Buttmann, Nina ^a   Bardenheuer, Kristina ^a  

^a ZEG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG HALF LIFE; DRUG TREATMENT FAILURE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; LIFE TABLE; MAJOR CLINICAL STUDY; OBESITY; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; PARITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SMOKING; TREATMENT DURATION; UNITED STATES; UNPLANNED PREGNANCY; VOMITING;

ADULT; BODY MASS INDEX; CONTRACEPTIVES, ORAL, HORMONAL; EUROPE; FEMALE; HUMANS; PREGNANCY; PREGNANCY RATE; PROGESTINS; PROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 78650781153     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31820095a2     Document Type: Article

References (23)

1. Kost K, Singh S, Vaughan B, Trussell J, Bankole A. Estimates of contraceptive failure from the 2002 National Survey of Family Growth. Contraception 2008;77:10-21.
2. Dinger JC, Cronin M, Mö hner S, et al. Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol 2009;201263.e1-9.
3. Dinger JC, Heinemann LA, Kühl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives (EURAS-OC) based on 142,475 women-years of observation. Contraception 2007;75:344-54.
4. Klipping C, Duijkers I, Trummer D, Marr J. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 2008;78:16-25.
5. Spona J, Elstein M, Feichtinger W, Sullivan H, Lüdicke F, Müller U, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996;54:71-7.
6. Sullivan H, Furniss H, Spona J, Elstein M. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertil Steril 1999;72:115-20.
7. Willis SA, Kuehl TJ, Spiekerman AM, Sulak PJ. Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. Contraception 2006;74:100-3.
8. Krattenmacher R. Drospirenone: pharmacology and pharma-cokinetics of a unique progestogen. Contraception 2000;62: 29-38.
9. European Medicines Agency Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women, July 27, 2005. Available at http://www.emea.europa.eu/pdfs/human/ewp/ 051998en.pdf. Retrieved April 14, 2010.
10. Gerlinger C, Endrikat J, van der Meulen EA, Dieben TO, Dü sterberg B. Recommendation for confidence interval and sample size calculation for the Pearl Index. Eur J Contracept Reprod Health Care 2003;8:87-92.
11. Brunner Huber LR, Hogue CJ. The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception. Matern Child Health J 2005;9:413-20.
12. Holt VL, Scholes D, Wicklund KG, Cushing-Haugen KL, Daling JR. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol 2005;105:46-52.
13. Darney P. Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials. Contraception 1993;48:323-37.
14. Ferguson H, Vree ML, Wilpshaar J, Eskes TK. Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive. Eur J Contracept Reprod Health Care 2000;5:35-45.
15. Grubb GS, Archer DF, Constantine GD. Differences between the United States and Europe in clinical trials of hormonal contraceptive efficacy. Obstet Gynecol 2008;111:63S.
16. Hamilton BE, Sutton PD, Ventura SJ. Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States. Natl Vital Stat Rep 2003;51:1-94.
17. Larsen U, Yan S. The age pattern of fecundability: an analysis of French Canadian and Hutterite birth histories. Soc Biol 2000;47:34-50.
18. Wood JW. Fecundity and natural fertility in humans. Oxf Rev Reprod Biol 1989;11:61-109.
19. Trussell J. Methodological pitfalls in the analysis of contraceptive failure. Stat Med 1991;10:201-20.
20. Howe G, Westhoff C, Vessey M, Yeates D. Effects of age, cigarette smoking, and other factors on fertility: findings in a large prospective study. Br Med J (Clin Res Ed) 1985;290: 1697-700.
21. Trussell J, Schwarz EB, Guthrie K. Obesity and oral contraceptive pill failure. Contraception 2009;79:334-8.
22. Friedman CI, Kim MH. Obesity and its effect on reproductive function. Clin Obstet Gynecol 1985;28:645-63.
23. Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol 1991; 133:635-48.